潘金莲被吸乳揉到高潮的视频,久久99久久99精品免观看,在电影院里拨开内裤挺进,护士交换粗吟配乱大交动态图

He'nan Kangtai Pharmaceutical Co., Ltd. is located at No. 338 of Kangtai Road of Sishui Town in Xingyang City (40 kilometers away from of Zhengzhou City in the west), and our factory covers an area of 36,000 square meters. Designated by the former Henan Province Food and Drug Administration, our company is a specialized manufacturer of third-generation quinolone antimicrobial pharmaceutical APIs and intermediates, and our main products are APIs: NORFLOXACIN (fluperacid), Gatifloxacin mesylate, Fleroxacin, Lomefloxacin Hydrochloride, Norfloxacin hydrochloride and Norfloxacin Nicotinic.

At present, our company has 98 employees and 21 technicians, including 2 senior titles and 35 junior and intermediate titles. On January 28, 2000, our company was approved for import and export rights, and our company has fixed assets of more than CNY 40 million.

Over the years, our company has continuously deepened the reform of the enterprise, increased investment in science and technology, worked on the high, precise and cutting-edge technology and products,and then developed a number of high-tech products and put them on the market, and successfully obtained good social and economic benefits. At present, our leading products are quinolone chemical synthetic APIs (NORFLOXACIN, Gatifloxacin mesylate, Fleroxacin) and their series of pharmaceutical intermediates. Especially, NORFLOXACIN won the "First Prize of Henan Technology Progress Award" and was listed as "Key Project of High-tech Industrialization in Henan Province"; Our Gatifloxacin mesylate (API, the national first-class new drug) won the "Second Prize of Henan Province Technology Progress Award", "Top Ten Influential Technological Achievements Award of Henan Province", and "National Key New Product". On December 1, 2022, our company successfully obtained the certification of "National high-tech enterprise 2022"; our company was once again recognized as a "specialized-precise-special-new" small and medium-sized enterprise in Zhengzhou in 2022; in February 2023, our company was rated as an "excellent private enterprise in Xingyang City".